All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Ozempic and Fertility

Ozempic should be stopped at least two months before trying to conceive. Learn how Ozempic affects fertility, the 'Ozempic baby' phenomenon,...

By Dr. Michael Torres, MD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Michael Torres, MD · Reviewed by Dr. David Kim, MD, FACE

Ozempic and Fertility custom 2026 header image for GLP-1 Weight Loss
Custom header image for Ozempic and Fertility, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Ozempic and Fertility

Ozempic should be stopped at least two months before trying to conceive. Learn how Ozempic affects fertility, the 'Ozempic baby' phenomenon,...

Short answer

Ozempic should be stopped at least two months before trying to conceive. Learn how Ozempic affects fertility, the 'Ozempic baby' phenomenon,...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, hormone labs and monitoring

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Ozempic should be stopped at least two months before trying to conceive. Learn how Ozempic affects fertility, the 'Ozempic baby' phenomenon, contraception tips, and pregnancy planning.

Ozempic (semaglutide) should be discontinued at least two months before attempting to conceive, according to the manufacturer's prescribing information. While Ozempic isn't approved for use during pregnancy, the weight loss it produces may paradoxically improve fertility for patients struggling with obesity-related reproductive issues. Planning the timing of treatment and conception with your provider is important.

The so-called "Ozempic baby" trend has drawn significant public attention to the connection between GLP-1 medications and unexpected pregnancies. Understanding the facts behind this phenomenon, along with proper planning, helps patients find fertility decisions confidently.

The "Ozempic Baby" Phenomenon

Reports of unexpected pregnancies among women taking Ozempic and similar GLP-1 medications have become widespread. Several factors explain why this happens. Weight loss improves hormonal balance, particularly in women with PCOS or obesity-related anovulation. As body fat decreases, excess estrogen production drops, and ovulatory function can resume in women who had irregular or absent cycles for years.

Improved insulin sensitivity from Ozempic may further support regular ovulation in women with insulin-resistant conditions. The result is that women who assumed they couldn't conceive naturally find themselves pregnant, sometimes without realizing their fertility had been restored.

Why Ozempic Should Be Stopped Before Pregnancy

Ozempic's active ingredient, semaglutide, has a half-life of approximately seven days. The manufacturer recommends discontinuing the medication at least two months (roughly eight half-lives) before planned conception to ensure full clearance. For a complete cost breakdown, see our cheapest semaglutide options. For a complete cost breakdown, see our compare GLP-1 providers.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Ozempic and Fertility

This recommendation stems from animal reproductive studies that showed embryo-fetal harm at doses higher than human therapeutic levels, including pregnancy loss and structural abnormalities. Human data is limited because pregnant women are excluded from clinical trials. The two-month washout provides a safety margin to ensure the drug is effectively gone from your system before conception occurs.

For patients carrying excess weight, the fertility benefits of weight loss are well documented:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Restoration of regular menstrual cycles and ovulation
  • Improved egg quality and uterine receptivity
  • Higher success rates with IVF and other assisted reproduction
  • Reduced miscarriage risk
  • Better sperm parameters in male partners who also lose weight

Some reproductive endocrinologists now incorporate a pre-conception weight loss phase using Ozempic into their fertility treatment plans. The patient loses weight, stops Ozempic, completes the washout period, and then proceeds with conception or fertility treatment.

Contraception While Taking Ozempic

Because Ozempic slows gastric emptying, there's a theoretical concern that oral birth control pills may not be absorbed as effectively. While clinical studies haven't shown a definitive reduction in oral contraceptive efficacy with semaglutide specifically, many providers recommend a backup non-oral contraceptive method as a precaution. Options like IUDs, implants, and injectable contraceptives are unaffected by stomach motility changes.

Frequently Asked Questions

How long before trying to get pregnant should I stop Ozempic?

Stop Ozempic at least two months before attempting to conceive. This allows the medication to fully clear from your body, given its seven-day half-life. Your provider can help you create a timeline that balances weight loss goals with conception planning.

Does Ozempic cause infertility?

No, there's no evidence that Ozempic causes permanent infertility. In fact, the opposite may be true for many patients. The weight loss and metabolic improvements from Ozempic can restore fertility in people whose reproductive function was impaired by obesity or insulin resistance.

What happens if I find out I am pregnant while on Ozempic?

Discontinue Ozempic immediately and contact your healthcare provider. Brief early exposure during the first weeks of pregnancy hasn't been well studied in humans, but stopping promptly is the recommended course of action. Your provider will guide you through appropriate monitoring.

Can Ozempic affect male fertility?

Direct effects of Ozempic on male fertility aren't well studied in humans. Animal data hasn't shown significant negative reproductive effects at standard doses. Indirectly, the weight loss from Ozempic can improve testosterone levels, sperm count, and sperm quality in men who are overweight or obese. Ozempic for weight loss

Should I use extra contraception while on Ozempic?

If you rely on oral birth control pills, consider adding a backup method or switching to a non-oral contraceptive while taking Ozempic. The medication's effect on gastric emptying could theoretically reduce pill absorption. IUDs, implants, and other non-oral methods aren't affected by this concern.

This content is for informational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider regarding fertility and medication decisions.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Ozempic evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Ozempic and Fertility, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Ozempic and Fertility research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Ozempic should be stopped at least two months before trying to conceive. Learn how Ozempic affects fertility, the 'Ozempic baby' phenomenon, contraception tips, and pregnancy planning. "Ozempic and Fertility" is most useful when you treat it as decision prep, not a shortcut. The page is built around patient education and clinical context, with the highest-value checks sitting around semaglutide. Because this article has 5 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the answer affects treatment, cost, pharmacy choice, or dosing, bring the specifics to a licensed clinician before acting.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Ozempic and Fertility

This update makes Ozempic and Fertility more specific by tying semaglutide, tirzepatide, retatrutide, testosterone, cash-pay pricing, safety signals to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable glp-1 weight loss summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

Ozempic and Fertility custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Ozempic and Fertility, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Ozempic and Fertility, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Michael Torres, MD

Endocrinologist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.